Quest Diagnostics
$17.38 B
Share price
Change (1 day)
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Market capitalization of Quest Diagnostics (DGX)

Market cap: $17.38 Billion

As of December 2022 Quest Diagnostics has a market cap of $17.38 Billion. This makes Quest Diagnostics the world's 965th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Quest Diagnostics from 2001 to 2022

End of year Market Cap

Year Market cap Change
2022$17.38 B-18.11%
2021$21.22 B32.15%
2020$16.06 B13.07%
2019$14.20 B26.35%
2018$11.24 B-16.26%
2017$13.42 B5.36%
2016$12.74 B25.24%
2015$10.17 B5.35%
2014$9.65 B25.25%
2013$7.70 B-16.43%
2012$9.22 B0.73%
2011$9.15 B-0.59%
2010$9.21 B-16.75%
2009$11.06 B8.99%
2008$10.15 B-1.13%
2007$10.27 B-0.09%
2006$10.27 B0.62%
2005$10.21 B5.66%
2004$9.66 B28.64%
2003$7.51 B34.85%
2002$5.57 B-19.05%
2001$6.88 B

End of Day market cap according to different sources

On Dec 1st, 2022 the market cap of Quest Diagnostics was reported to be:

$18.72 Billion
by Yahoo Finance
$17.38 Billion
by CompaniesMarketCap
$17.38 Billion
by Nasdaq
$17.38 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$21.42 B 23.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.82 B-83.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$32.28 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.41 B-91.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.48 B-33.89%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$95 M-99.45%๐Ÿ‡บ๐Ÿ‡ธ USA